Obinutuzumab, a new anti-CD20 antibody, and chlorambucil are active and effective in anti-myelin-associated glycoprotein antibody polyneuropathy
Author:
Affiliation:
1. Neurology Unit; Department of Neuroscience; University of Padova; Padova Italy
2. Hematology and Clinical Immunology Unit; Department of Medicine; University of Padova; Padova Italy
3. CEMES; Data Medica Group; Padova Italy
Publisher
Wiley
Subject
Clinical Neurology,Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.13838/fullpdf
Reference10 articles.
1. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies;Lunn;Cochrane Database Syst Rev,2016
2. Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity;Mossner;Blood,2010
3. Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study;Goede;Leukemia,2015
4. Neurophysiological examination of dorsal sural nerve;Frigeni;Muscle Nerve,2012
5. Integrated CLL scoring system, a new and simple index to predict time to treatment and overall survival in patients with chronic lymphocytic leukemia;Visentin;Clin Lymphoma Myeloma Leuk,2015
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic potentials of adoptive cell therapy in immune-mediated neuropathy;Journal of Autoimmunity;2024-12
2. Prevalence and clinical profiles of anti‐myelin‐associated glycoprotein neuropathy in Japan: A nationwide survey study of 133 patients;European Journal of Neurology;2024-02-20
3. Paraproteinemic Neuropathies;CONTINUUM: Lifelong Learning in Neurology;2023-10
4. Mutational Profile in 75 Patients With Anti–Myelin-Associated Glycoprotein Neuropathy;Neurology Neuroimmunology & Neuroinflammation;2023-07
5. Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular Endplates;Neurology Neuroimmunology & Neuroinflammation;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3